ASIT Biotech S.A.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Efficacy and Safety of Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis (NCT03724240) | ASIT Biotech S.A. | 2019-01-02 |
| Safety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients (NCT03094845) | ASIT Biotech S.A. | 2016-09-28 |
Track ASIT Biotech S.A. automatically
Every clearance here is in the API, with alerts when new ones post.